<p>Apixaban is a factor Xa inhibitor indicated:</p>

<ul>
	<li>To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation</li>
	<li>For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery</li>
	<li>For the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy</li>
</ul>